Valuation: Sagittarius Life Science Corp

Market Cap 3.09B 94.7M 84.82M 78.02M 70.69M 132M 8.99B 135M 930M 373M 4.73B 355M 348M 14.92B P/E 2024
-21.4x
P/E 2025 -55.9x
Enterprise Value 2.29B 70.09M 62.77M 57.74M 52.32M 97.8M 6.66B 99.63M 689M 276M 3.5B 263M 257M 11.04B EV / Sales 2024
1.9x
EV / Sales 2025 7.69x
Free-Float
29.82%
Yield 2024 *
-
Yield 2025 -
08-14 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 CI
05-14 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
03-16 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2025 CI
11-13 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
12/08/25 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 CI
14/05/25 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
12/03/25 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2024 CI
14/11/24 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 CI
13/08/24 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 CI
15/05/24 Sagittarius Life Science Corp Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
21/03/24 Sagittarius Life Science Corp Reports Earnings Results for the Full Year Ended December 31, 2023 CI
14/11/23 Sagittarius Life Science Corp Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
14/08/23 Sagittarius Life Science Corp Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
1 day+1.22%
1 week-0.87%
1 month-2.24%
3 months-3.89%
6 months-18.59%
Current year-10.82%
1 week 44
Extreme 44
46.3
1 month 44
Extreme 44
47.5
Current year 44
Extreme 44
67
1 year 43.95
Extreme 43.95
67
3 years 21.3
Extreme 21.3
67
5 years 20.65
Extreme 20.65
79.2
10 years 20.65
Extreme 20.65
150
Manager TitleAgeSince
Chief Executive Officer - 29/09/2019
Director of Finance/CFO - 14/11/2019
Director TitleAgeSince
Chairman - 28/04/2004
Director/Board Member - 16/06/2015
Director/Board Member - 28/04/2004
Change 5-day change 1-year change 3-year change Capi.($)
+1.22%-0.87%-12.52%+0.66% 94.7M
+2.28%+1.19%+10.17%-13.62% 264B
+3.85%+1.79%+13.02%-1.92% 82.2B
+1.77%+5.27%-14.55%+16.69% 47.06B
-.--%+0.73%+18.04%+547.12% 45.83B
+0.93%-4.03%+27.06%+7.46% 37.07B
+3.33%-2.38%-2.37%-11.60% 33.28B
-0.39%+1.07%+17.04%+86.79% 31.02B
+0.96%+0.96%-8.53%-7.41% 30B
+1.84%-1.85%-1.58%-22.63% 28.86B
Average +1.58%-0.16%+4.58%+60.15% 59.99B
Weighted average by Cap. +2.03%+0.63%+8.42%+39.69%

Financials

2024 2025
Net sales 468M 14.33M 12.84M 11.81M 10.7M 20M 1.36B 20.38M 141M 56.53M 716M 53.8M 52.65M 2.26B 346M 10.61M 9.5M 8.74M 7.92M 14.8M 1.01B 15.08M 104M 41.83M 530M 39.8M 38.96M 1.67B
Net income -48.53M -1.49M -1.33M -1.23M -1.11M -2.08M -141M -2.11M -14.61M -5.87M -74.29M -5.58M -5.46M -234M -49.56M -1.52M -1.36M -1.25M -1.13M -2.12M -144M -2.16M -14.92M -5.99M -75.87M -5.7M -5.58M -239M
Net Debt -150M -4.6M -4.12M -3.79M -3.43M -6.42M -437M -6.54M -45.2M -18.15M -230M -17.27M -16.9M -725M -803M -24.61M -22.04M -20.28M -18.37M -34.34M -2.34B -34.99M -242M -97.07M -1.23B -92.37M -90.41M -3.88B
Projected Income Statement - Annual - Sagittarius Life Science Corp
Logo Sagittarius Life Science Corp
Sagittarius Life Science Corp. is a Taiwan-based company principally engaged in the research, development, production and sales of health products. The Company's main products include various types of nutrition and health formulations, natural and organic food, beverages, probiotic fermentation products, beauty care ingredients, Chinese herbal medicines, plant new medicines and health supplies. The Company also provides related technical services for the research and development of Chinese and western pharmaceutical products. The Company distributes its products in domestic market and to overseas markets, such as the rest areas of Asia and the Americas.
Employees
112
Date Price Change Volume
30/10/26 NT$45.75 +1.22% 83,622
29/10/26 NT$45.20 -1.74% 12,111
28/10/26 NT$46.00 -0.22% 17,266
27/10/26 NT$46.10 -0.11% 6,262
  1. Stock Market
  2. Stocks
  3. 3205 Stock